Cargando…

Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives

The study of Hodgkin lymphoma (HL), with its unique microenvironment and long-term follow-up, has provided exceptional insights into several areas of tumor biology. Findings in HL have not only improved our understanding of human carcinogenesis, but have also pioneered its translation into the clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuceu, Corina, Hempel, William M., Sabatier, Laure, Bosq, Jacques, Carde, Patrice, M’kacher, Radhia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923346/
https://www.ncbi.nlm.nih.gov/pubmed/29587466
http://dx.doi.org/10.3390/cancers10040091
_version_ 1783318320421797888
author Cuceu, Corina
Hempel, William M.
Sabatier, Laure
Bosq, Jacques
Carde, Patrice
M’kacher, Radhia
author_facet Cuceu, Corina
Hempel, William M.
Sabatier, Laure
Bosq, Jacques
Carde, Patrice
M’kacher, Radhia
author_sort Cuceu, Corina
collection PubMed
description The study of Hodgkin lymphoma (HL), with its unique microenvironment and long-term follow-up, has provided exceptional insights into several areas of tumor biology. Findings in HL have not only improved our understanding of human carcinogenesis, but have also pioneered its translation into the clinics. HL is a successful paradigm of modern treatment strategies. Nonetheless, approximately 15–20% of patients with advanced stage HL still die following relapse or progressive disease and a similar proportion of patients are over-treated, leading to treatment-related late sequelae, including solid tumors and organ dysfunction. The malignant cells in HL are characterized by a highly altered genomic landscape with a wide spectrum of genomic alterations, including somatic mutations, copy number alterations, complex chromosomal rearrangements, and aneuploidy. Here, we review the chromosomal instability mechanisms in HL, starting with the cellular origin of neoplastic cells and the mechanisms supporting HL pathogenesis, focusing particularly on the role of the microenvironment, including the influence of viruses and macrophages on the induction of chromosomal instability in HL. We discuss the emerging possibilities to exploit these aberrations as prognostic biomarkers and guides for personalized patient management.
format Online
Article
Text
id pubmed-5923346
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-59233462018-05-03 Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives Cuceu, Corina Hempel, William M. Sabatier, Laure Bosq, Jacques Carde, Patrice M’kacher, Radhia Cancers (Basel) Review The study of Hodgkin lymphoma (HL), with its unique microenvironment and long-term follow-up, has provided exceptional insights into several areas of tumor biology. Findings in HL have not only improved our understanding of human carcinogenesis, but have also pioneered its translation into the clinics. HL is a successful paradigm of modern treatment strategies. Nonetheless, approximately 15–20% of patients with advanced stage HL still die following relapse or progressive disease and a similar proportion of patients are over-treated, leading to treatment-related late sequelae, including solid tumors and organ dysfunction. The malignant cells in HL are characterized by a highly altered genomic landscape with a wide spectrum of genomic alterations, including somatic mutations, copy number alterations, complex chromosomal rearrangements, and aneuploidy. Here, we review the chromosomal instability mechanisms in HL, starting with the cellular origin of neoplastic cells and the mechanisms supporting HL pathogenesis, focusing particularly on the role of the microenvironment, including the influence of viruses and macrophages on the induction of chromosomal instability in HL. We discuss the emerging possibilities to exploit these aberrations as prognostic biomarkers and guides for personalized patient management. MDPI 2018-03-26 /pmc/articles/PMC5923346/ /pubmed/29587466 http://dx.doi.org/10.3390/cancers10040091 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Cuceu, Corina
Hempel, William M.
Sabatier, Laure
Bosq, Jacques
Carde, Patrice
M’kacher, Radhia
Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives
title Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives
title_full Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives
title_fullStr Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives
title_full_unstemmed Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives
title_short Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives
title_sort chromosomal instability in hodgkin lymphoma: an in-depth review and perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923346/
https://www.ncbi.nlm.nih.gov/pubmed/29587466
http://dx.doi.org/10.3390/cancers10040091
work_keys_str_mv AT cuceucorina chromosomalinstabilityinhodgkinlymphomaanindepthreviewandperspectives
AT hempelwilliamm chromosomalinstabilityinhodgkinlymphomaanindepthreviewandperspectives
AT sabatierlaure chromosomalinstabilityinhodgkinlymphomaanindepthreviewandperspectives
AT bosqjacques chromosomalinstabilityinhodgkinlymphomaanindepthreviewandperspectives
AT cardepatrice chromosomalinstabilityinhodgkinlymphomaanindepthreviewandperspectives
AT mkacherradhia chromosomalinstabilityinhodgkinlymphomaanindepthreviewandperspectives